نتائج البحث

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

• Authors : Robert W. Grady; Daniele Alberti; Axel Krebs-Brown

Subjects: Adult; Male; medicine.medical_specialty

• Source: The Lancet. 361:1597-1602

تفاصيل العنوان

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial.

• Authors : Nisbet-Brown E; Department of Paediatrics, Harvard Medical School, Boston, MA, USA.; Olivieri NF

Subjects: Benzoates/Benzoates/Benzoates/*therapeutic use ; Deferoxamine/Deferoxamine/Deferoxamine/*therapeutic use ; Iron Overload/Iron Overload/Iron Overload/*drug therapy

• Source: Lancet (London, England) [Lancet] 2003 May 10; Vol. 361 (9369), pp. 1597-602.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Print ISSN: 0140-6736 (Print)

تفاصيل العنوان

Do we need more iron-chelating drugs?

• Authors : Kontoghiorghes GJ

Subjects: Benzoates/Benzoates/Benzoates/*pharmacokinetics ; Benzoates/Benzoates/Benzoates/*therapeutic use ; Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*pharmacokinetics

• Source: Lancet (London, England) [Lancet] 2003 Aug 09; Vol. 362 (9382), pp. 495-6.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

تفاصيل العنوان

Do we need more iron-chelating drugs?

• Authors : George J. Kontoghiorghes

Subjects: Iron Overload; Iron Chelating; business.industry

• Source: Lancet (London, England). 362(9382)

تفاصيل العنوان

The Egyptian experience with oral iron chelators.

• Authors : El Beshlawy A; Hematology Department, Pediatric Hospital, Cairo University, Egypt.

Subjects: Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*therapeutic use; Benzoates/Benzoates/Benzoates/therapeutic use ; Deferasirox

• Source: Hematology (Amsterdam, Netherlands) [Hematology] 2005; Vol. 10 Suppl 1, pp. 174-5.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Print ISSN: 1024-5332 (Print)

تفاصيل العنوان

Effects of ICL670 (deferasirox) on cardiac iron concentrations

• Authors : George J. Kontoghiorghes

Subjects: business.industry; Iron; Myocardium

• Source: The Lancet. 366:804

تفاصيل العنوان

Effects of ICL670 (deferasirox) on cardiac iron concentrations.

• Authors : Kontoghiorghes GJ

Subjects: Benzoates/Benzoates/Benzoates/*adverse effects ; Iron/Iron/Iron/*metabolism ; Myocardium/Myocardium/Myocardium/*metabolism

• Source: Lancet (London, England) [Lancet] 2005 Sep 3-9; Vol. 366 (9488), pp. 804.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic)

تفاصيل العنوان

The Egyptian experience with oral iron chelators

• Authors : Amal El Beshlawy

Subjects: Iron Overload; Iron Chelating; business.industry

• Source: Hematology (Amsterdam, Netherlands). 10

تفاصيل العنوان

Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.

• Authors : Kontoghiorghes GJ; Postgraduate Research Institute of Science, Technology, Environment and Medicine, Limassol, Cyprus.

Subjects: Chelation Therapy/Chelation Therapy/Chelation Therapy/*trends ; Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*therapeutic use ; Iron Overload/Iron Overload/Iron Overload/*drug therapy

• Source: Hemoglobin [Hemoglobin] 2006; Vol. 30 (2), pp. 329-47.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print Cited Medium: Print ISSN: 0363-0269

تفاصيل العنوان

Oral drug for iron overload.

Subjects: Benzoates/Benzoates/Benzoates/*therapeutic use ; Iron Overload/Iron Overload/Iron Overload/*drug therapy ; Triazoles/Triazoles/Triazoles/*therapeutic use

• Source: FDA consumer [FDA Consum] 2006 Jan-Feb; Vol. 40 (1), pp. 5.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان